$WELL

Welltower (WELL), Ventas (VTR), and Omega Healthcare (OHI) are REITs benefiting from a demographic wave of aging baby boomers. Welltower reported Q2 2026 revenue of $3.54B, up 40.9% YoY, and raised FFO guidance. Ventas saw 9% YoY FFO growth and shifted focus to SHOP. Omega Healthcare improved AFFO and raised its dividend. All three companies are positioned to capitalize on increased demand for senior housing and skilled nursing facilities.

Morgan Stanley's Ronald Kamdem expects senior housing REITs to continue outperforming due to aging population and high demand. Welltower (WELL) and American Healthcare REIT (AHR) are rated overweight, with price targets of $251 and implied upside, respectively. Ventas (VTR) is rated equal weight. All three REITs show strong occupancy and acquisition growth potential, with Welltower's dividend yield at 1.44%.

Wells Fargo maintained an Overweight rating on Welltower (WELL) and raised its price target to $266 from $237. Welltower's stock is currently 20.4% overvalued according to GF Value™, with a GF Score™ of 84/100. The company has a market cap of $174.46 billion and operates in the REITs industry. Insider activity shows significant confidence with $2.41 million in insider buys over the last three months.

Morgan Stanley maintained an Overweight rating on Welltower (WELL) and raised its price target to $251 from $215. Welltower's stock is currently trading at $241.48, which is 20.1% above its GF Value™ of $201.04, according to GuruFocus. The company has a GF Score™ of 84/100, indicating strong overall performance, with notable strengths in growth and profitability. Insider activity shows $2.4 million in buying over the last three months.

Barclays raised its price target on Welltower from $254 to $259, maintaining an Equalweight rating. The stock is currently trading at $234.58, down 1.47% on the day and 0.48% over a month, but up 28.26% year-to-date.

Energy Vault (NRGV) director bought 27,472 shares at $3.88 each. Keurig Dr Pepper (KDP) director acquired 7,862 shares at $31.83. Welltower (WELL) director purchased 10,000 shares at $239.47-$242.06. American Assets (AAT) chairman bought 79,729 shares at $22.74-$22.89. Lumentum (LITE) exec sold 38,604 shares at $842.22-$860.05. Tempus AI (TEM) CEO sold 238,052 shares at $64.03-$70.58. CoreWeave (CRWV) CEO sold 307,692 shares at $88.31-$89.93. Illumina (ILMN) director sold 375,541 shares at $224.

Mizuho identified Welltower Inc (WELL) and Ventas Inc (VTR) as top picks in the senior housing REIT sector, with price targets of $260 and $104 respectively. WELL trades at a premium multiple due to superior cash flow growth, while VTR shows strong revenue growth. Both companies reported Q2 2026 results, with WELL surpassing revenue forecasts but missing on EPS, and VTR meeting earnings expectations and exceeding revenue forecasts.

Gundlach Andrew purchased 10,000 indirectly-held shares of WELLTOWER INC. (WELL) at an average of $240.76 ($239.47–$242.06, $2.41M total) across 4 trades over 2026-08-25 to 2026-08-26.

Welltower (WELL) director Dennis G. Lopez acquired 73 shares of common stock on 2026-08-20, linked to dividend equivalent rights on deferred stock units. The shares were valued at $237.40 each, bringing Lopez's total direct holdings to 18,597.57 shares. The transaction was not part of a Rule 10b5-1 plan.

Evans Senior Investments (ESI) arranged two skilled nursing portfolio sales. In Michigan, Welltower bought a three-facility, 347-bed portfolio; ESI cited about $990,000 in potential annual revenue gains from rate optimization and referral improvements. In New Mexico, ESI sold a three-facility, 360-bed Albuquerque portfolio under a triple-net lease with Genesis Healthcare operating. SixCap closed $4M financing for an Illinois SNF operator.